https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42669 Wed 31 Aug 2022 16:25:25 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46788 Wed 30 Nov 2022 13:21:42 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43692 Wed 28 Sep 2022 09:26:49 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54522 upper limit of normal) showed strong concurrent validity with worse airflow limitation, Medical Research Council breathlessness and COPD Assessment Test scores. Conclusion: Normative references for the mBorg/6MWD ratio are presented to assess breathlessness and leg discomfort responses to the 6MWT in COPD.]]> Wed 28 Feb 2024 16:18:53 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54409 upper limit of normal) during CPET.]]> Wed 28 Feb 2024 15:17:08 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45192 2, liver fat content of 8.37 ± 6.90%, HOMA-IR of 3.07 ± 2.33 and CRF of 21.52 ± 3.77 mL/kg/min participated in this study. CRF was inversely associated with liver fat content (r= − 0.28, p = 0.019) and HOMA-IR (r = − 0.40, p < 0.001). Participants with T2D had significantly higher liver fat content (+ 3.66%, p = 0.024) and HOMA-IR (+ 2.44, p < 0.001) than participants without T2D. Participants with T2D tended to have lower CRF than participants without T2D (− 1.5 ml/kg/min, p = 0.094). Conclusion: CRF was inversely associated with liver fat content and insulin resistance. Participants with T2D had lower CRF than those without T2D, however, the difference was not statistically significant. Further longitudinal studies are required to elucidate the relationship between CRF and the progression of obesity-related diseases such as T2D. Registration: ACTRN12614001220651 (retrospectively registered on the 19th November 2014) and ACTRN12614000723684 (prospectively registered on the 8th July 2014).]]> Wed 26 Oct 2022 14:25:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:2811 Wed 24 Jul 2013 22:54:53 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:2185 Wed 24 Jul 2013 22:54:20 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12678 Wed 24 Jul 2013 22:23:50 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37416 Wed 18 Nov 2020 09:52:50 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45952 Wed 13 Mar 2024 14:13:52 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46006 Wed 13 Mar 2024 14:07:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24278 Wed 11 Apr 2018 18:17:05 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20558 Wed 11 Apr 2018 17:17:31 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15776 Wed 11 Apr 2018 16:59:53 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12673 Wed 11 Apr 2018 16:58:10 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18243 Wed 11 Apr 2018 16:28:32 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12879 Wed 11 Apr 2018 14:10:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26678 Wed 11 Apr 2018 12:33:31 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:6812 Wed 11 Apr 2018 10:31:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14499 Wed 11 Apr 2018 10:21:55 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21621 Wed 11 Apr 2018 10:02:11 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34073 Wed 09 Mar 2022 16:04:01 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34497 Wed 09 Mar 2022 16:00:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13784 Wed 08 Jan 2020 11:29:43 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24601 Wed 04 Sep 2019 10:24:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52880 Tue 31 Oct 2023 10:44:58 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46689 Tue 29 Nov 2022 09:35:58 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46676 Tue 29 Nov 2022 09:28:29 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39549 Tue 26 Jul 2022 11:25:03 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39851 .05). Objective sleep onset latency increased from the Baseline to the Treatment phase in the control (stretching) group (p = .042). In contrast, the Cycling group exhibited improvements in sleep duration (p = .008) and sleep efficiency (p = .023) during the Treatment phase compared to the Baseline phase. Cycling also increased sleep duration (p = .005), decreased average wake bout (p = .040) and tended to increase sleep efficiency (p = .051) compared to stretching during the Treatment phase. Subjective sleep quality ratings did not differ between groups (p > .10). These preliminary findings suggest that moderate-intensity aerobic exercise may attenuate the sleep disturbances associated with cannabis withdrawal.]]> Tue 26 Jul 2022 09:52:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42492 Tue 23 Aug 2022 15:41:26 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51133 Tue 22 Aug 2023 15:57:59 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52540 Tue 17 Oct 2023 10:11:57 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54231 Tue 13 Feb 2024 12:28:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38413 Tue 07 Sep 2021 16:15:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4345 Tue 05 Jun 2018 11:07:03 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34974 Tue 03 Sep 2019 18:17:52 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41392 Tue 02 Aug 2022 17:47:29 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8558 Thu 30 Jan 2014 14:54:51 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8544 Thu 30 Jan 2014 14:42:50 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8549 Thu 30 Jan 2014 14:42:12 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8550 Thu 30 Jan 2014 14:39:42 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8555 Thu 30 Jan 2014 14:36:56 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52093 Thu 28 Sep 2023 14:29:07 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:499 Thu 25 Jul 2013 09:10:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:135 Thu 25 Jul 2013 09:09:35 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28021 Thu 22 Jun 2017 09:34:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29965 Thu 17 Mar 2022 14:41:51 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49930 Thu 15 Jun 2023 13:19:41 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44088 P =.001). This association was not present (P =.83), however, when age and sex were included in the regression model. Conclusion: In the Australian Diabetes, Obesity, and Lifestyle study dataset, there was no evidence that more TV viewing is independently associated with risk of stroke, although analyses may have been underpowered.]]> Thu 06 Oct 2022 15:48:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52227 Thu 05 Oct 2023 10:29:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9380 Sat 24 Mar 2018 10:45:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9372 Sat 24 Mar 2018 10:45:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9444 Sat 24 Mar 2018 10:44:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:11084 Sat 24 Mar 2018 10:33:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8283 150 minutes per week) physically active (69%). Almost half (43%) were still playing 12 months later (continuers). Continuers were more likely to perceive Lifeball had helped them to: feel fitter and healthier (91%); improve their social life (73%); and be more active (53%). No significant changes in continuers' physical activity, self-reported health status and quality of life measures were reported. The main reason for stopping playing was illness/injury unrelated to Lifeball. Conclusions: Lifeball mainly appealed to healthy, active older people.]]> Sat 24 Mar 2018 08:40:28 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8376 30, and with a history of arthritis but no significant association with other demographic variables. Conclusion: Pedometry is feasible in an elderly sample, and research involving pedometers must take days of the week into account.]]> Sat 24 Mar 2018 08:39:49 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7339 Sat 24 Mar 2018 08:35:12 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7161 Sat 24 Mar 2018 08:34:16 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1548 Sat 24 Mar 2018 08:30:41 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1436 Sat 24 Mar 2018 08:28:03 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1713 50% reduction in disability were glucose-lignocaine: 0.42 versus saline 0.36 and exercise: 0.36 versus normal activity: 0.38. There were no between group differences in any of the above measures. Conclusions. In chronic nonspecific low-back pain, significant and sustained reductions in pain and disability occur with ligament injections, irrespective of the solution injected or the concurrent use of exercises.]]> Sat 24 Mar 2018 08:27:38 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14490 Sat 24 Mar 2018 08:21:41 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12428 .05). Some metabolic outcomes improved at 24 months, although there were no between-group differences (P > .05). Conclusions: A reduction in BMI z score was sustained at 24 months by treatment with either program combination. The greatest effects were achieved through inclusion of a parent-centered diet program, indicating the importance of targeting parents within treatment and the possibility of targeting them exclusively in treating obese prepubertal children.]]> Sat 24 Mar 2018 08:17:46 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:11538 Sat 24 Mar 2018 08:14:09 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:11797 max) were determined in a sample of eight pilots using a progressive cycle ergometer protocol. Results: Of the 42 F/A-18 pilots who completed the questionnaire, 86% reported regular physical conditioning, mostly three times per week. Aerobic activities were the most common (83%), with running the most popular activity (55%). Anaerobic activities were reported by 26% of respondents. Most respondents reported doing more than one activity, with an average weekly training volume of 129 ± 77 min. The ergometer test results revealed a mean Vo₂_max of 50 ± 6 ml 0₂ ·kg· min⁻¹ Condusion: The high rates of participation in regular physical activity suggest that physical fitness is perceived as important by the fighter pilot operating in the high +Gz environment. The fighter pilots in this study participated in aerobic activities at a much higher rate than anaerobic activities. The aerobic fitness levels measured suggest that the pilots have good but not exceptionally high levels of aerobic power that are unlikely to influence +Gz tolerance.]]> Sat 24 Mar 2018 08:13:10 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12229 Sat 24 Mar 2018 08:08:07 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19452 Sat 24 Mar 2018 08:02:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19647 2max = 64.8 ± 4.5 mL·kg⁻¹·min⁻¹; mean ± SD) undertook four cycling time trials (TT), each requiring the completion of a set amount of work (7 kJ·kg⁻¹ BM) in the shortest possible time. Participants were randomized into a fed or nonfed condition and orally ingested 2.8 mg·kg⁻¹ BM of PSE or a placebo (PLA) 90 min before exercise; in the fed trials, they consumed a meal providing 1.5 g·kg⁻¹ BM of CHO. Venous blood was sampled at 30, 50, and 70 min and pre–warm-up and postexercise for the analysis of plasma PSE and catecholamine concentrations, and urine was also collected for the analysis of PSE concentration. Results: Independent of the preexercise meal, 2.8 mg·kg⁻¹ BM of PSE did not significantly improve cycling TT performance. The fed trials resulted in lower plasma PSE concentrations at all time points compared with the nonfed trials. Both plasma epinephrine and blood lactate concentrations were higher in the PSE compared with the PLA trials, and preexercise and postexercise urinary PSE concentrations were significantly higher than the threshold (150 µg·mL⁻¹) used by WADA to determine illicit PSE use. Conclusion: Irrespective of the preexercise meal, cycling TT performance of approximately 30 min was not improved after PSE supplementation. Furthermore, 2.8 mg·kg⁻¹ BM of PSE taken 90 min before exercise, with or without food, resulted in urinary PSE concentrations exceeding the present WADA threshold.]]> Sat 24 Mar 2018 08:01:08 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21831 0.05) of hypothalamic–pituitary–adrenal axis stress hormones, plasma interleukin-6, the magnitude of leukocytosis and neutrophilia and changes in neutrophil function. Conclusion: Acute DC consumption may affect insulin, glucose, antioxidant status and oxidative stress responses, but has minimal effects on immunoendocrine responses, to prolonged exercise.]]> Sat 24 Mar 2018 07:58:43 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17988 Sat 24 Mar 2018 07:56:20 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19684 Sat 24 Mar 2018 07:53:50 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18526 Sat 24 Mar 2018 07:50:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5515 Sat 24 Mar 2018 07:46:42 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5251 Sat 24 Mar 2018 07:46:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5807 Sat 24 Mar 2018 07:44:55 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26114 Sat 24 Mar 2018 07:41:06 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28140 Sat 24 Mar 2018 07:36:38 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22176 Sat 24 Mar 2018 07:14:59 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46633 Mon 28 Nov 2022 15:37:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50014 Mon 26 Jun 2023 14:39:33 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32314 Mon 23 Sep 2019 12:52:02 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32226 Mon 23 Sep 2019 12:51:57 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32688 Mon 23 Sep 2019 12:49:55 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32769 Mon 23 Sep 2019 11:36:52 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21859 Mon 23 Sep 2019 10:35:56 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22644 Mon 23 Jul 2018 13:24:16 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42376 Mon 22 Aug 2022 14:29:29 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13462 Mon 21 Oct 2013 11:06:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48259 Mon 13 Mar 2023 14:39:38 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50820 Mon 07 Aug 2023 14:07:44 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38647 Mon 06 Dec 2021 16:41:16 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48093 Fri 24 Feb 2023 15:24:02 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38018 Fri 23 Jul 2021 15:47:31 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35151 Fri 21 Jun 2019 14:44:56 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33350 Fri 19 Oct 2018 12:56:50 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41744  15 years), and individuals engaging in sufficient levels of aerobic exercise training (AET) engaged in sufficient levels of RET (p < 0.05). Conclusions: The prevalence of Australian’s participating in regular RET programs is low and only a small proportion of participants meet ACSM guidelines for the quantity and quality of RET that is likely to provide health benefits. This has implications for public health policy and the future development and promotion of population-level RET guidelines.]]> Fri 12 Aug 2022 11:21:31 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51372 Fri 01 Sep 2023 13:41:20 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34907 interaction = -1.3 s, 95% confidence interval [CI] -2.6 to 0.0), whole-body lean mass (ß_interaction = 1194 g, 95% CI 234 to 2153) and ASM mass (ß_interaction = 562 g, 95% CI 49 to 1075), and approached significance for fat mass (ß_interaction = -1107 g, 95% CI -2346 to 132), with greater benefits for men previously on long-term ADT. At 6 months, the intervention effects on chair rise time -1.5 s (95% CI -2.5 to -0.5), whole-body lean mass 824 g (95% CI 8 to 1640), ASM mass 709 g (95% CI 260 to 1158), and fat mass -1377 g (95% CI -2156 to -598) were significant for men previously on long-term ADT, but not for men on short-term ADT. At 12 months, the intervention effects for men on long-term ADT remained significant for the chair rise, with improved performance (-2.0 s, 95% CI -3.0 to -1.0) and increased ASM (537 g, 95% CI 153 to 921). Time on ADT did not moderate the exercise effects on muscle strength, nor did time since ADT cessation moderate any intervention effects. Similarly, testosterone and baseline values of the outcome had negligible moderator effects. Conclusions: Men with PCa previously treated long-term with ADT respond more favourably to exercise in terms of lower body muscle performance and body composition (lean and fat mass, and ASM) than those with short-term ADT exposure. As a result, men who were formerly on long-term androgen suppression regimens should be especially prescribed exercise medicine interventions to alleviate residual treatment-related adverse effects.]]> Fri 01 Apr 2022 09:25:19 AEDT ]]>